Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-12-14

Clinical Trial Update: Patient Satisfaction After Switching to Oral Testosterone Undecanoate [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating patient satisfaction after switching to oral testosterone undecanoate for testosterone deficiency has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oral testosterone undecanoate (testosterone undecanoate)

Snippet

Sponsor: University of Miami | Conditions: Testosterone Deficiency | Phase 4 | Status: COMPLETED | Results posted: 2023-12-14